182 related articles for article (PubMed ID: 23073054)
21. Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma.
Bauduer F
Br J Haematol; 2001 Mar; 112(4):1085-6. PubMed ID: 11324638
[No Abstract] [Full Text] [Related]
22. Antibody and immunomodulatory agents in the treatment of indolent non-Hodgkin's lymphoma.
LaCasce AS; Freedman AS
Semin Hematol; 2008 Apr; 45(2):85-9. PubMed ID: 18381102
[TBL] [Abstract][Full Text] [Related]
23. Ten years of rituximab in NHL.
Winter MC; Hancock BW
Expert Opin Drug Saf; 2009 Mar; 8(2):223-35. PubMed ID: 19243307
[TBL] [Abstract][Full Text] [Related]
24. Factors predicting the response to rituximab in indolent lymphoma.
Lee D
Clin Lymphoma; 2003 Jun; 4(1):19-21. PubMed ID: 12837149
[No Abstract] [Full Text] [Related]
25. [THE MECHANISMS OF ACTION OF RITUXIMAB].
Gil'deeva GN; Kudlai DA; Luk'yanov SV
Eksp Klin Farmakol; 2015; 78(12):51-6. PubMed ID: 27051930
[TBL] [Abstract][Full Text] [Related]
26. Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties.
Klein C; Lammens A; Schäfer W; Georges G; Schwaiger M; Mössner E; Hopfner KP; Umaña P; Niederfellner G
MAbs; 2013; 5(1):22-33. PubMed ID: 23211638
[TBL] [Abstract][Full Text] [Related]
27. [Monoclonal antibody therapy for non-Hodgkin's lymphoma].
Paul F; Rossi JF; Cartron G
Rev Prat; 2010 Jan; 60(1):59-63. PubMed ID: 20222313
[TBL] [Abstract][Full Text] [Related]
28. [Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma].
Mihaljević B; Janković S; Jaković L; Jovanović MP; Andelić B; Milosević V; Sretenović A; Virijević M; Petrovic M
Vojnosanit Pregl; 2008 Mar; 65(3):229-33. PubMed ID: 18494271
[No Abstract] [Full Text] [Related]
29. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
Collins-Burow B; Santos ES
Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
[TBL] [Abstract][Full Text] [Related]
30. Rituximab in the treatment of non-Hodgkin's lymphoma--a critical evaluation of randomized controlled trials.
Griffin MM; Morley N
Expert Opin Biol Ther; 2013 May; 13(5):803-11. PubMed ID: 23560506
[TBL] [Abstract][Full Text] [Related]
31. Treatment of low-grade B-cell lymphoma with the monoclonal antibody rituximab.
Dillman RO
Semin Oncol; 2003 Aug; 30(4):434-47. PubMed ID: 12939712
[TBL] [Abstract][Full Text] [Related]
32. [Rituximab].
Okamoto R; Maeda Y; Sasaki T
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1085-93. PubMed ID: 12938262
[TBL] [Abstract][Full Text] [Related]
33. New treatment approaches to indolent non-Hodgkin's lymphoma.
Seymour JF
Semin Oncol; 2004 Feb; 31(1 Suppl 2):27-32. PubMed ID: 15042532
[TBL] [Abstract][Full Text] [Related]
34. [Clinical use of monoclonal antibodies in malignant lymphomas].
Schnell R; Hiddemann W; Diehl V; Engert A
Internist (Berl); 2001 Jun; 42(6):815-6, 819-26. PubMed ID: 11449628
[No Abstract] [Full Text] [Related]
35. The future of CD20 monoclonal antibody therapy in B-cell malignancies.
Czuczman MS; Gregory SA
Leuk Lymphoma; 2010 Jun; 51(6):983-94. PubMed ID: 20367564
[TBL] [Abstract][Full Text] [Related]
36. Rituximab resistance.
Rezvani AR; Maloney DG
Best Pract Res Clin Haematol; 2011 Jun; 24(2):203-16. PubMed ID: 21658619
[TBL] [Abstract][Full Text] [Related]
37. Intrapleural instillation of rituximab for the treatment of malignant pleural effusions in NHL.
Schmidt HH; Renner H; Linkesch W
Haematologica; 2004 Nov; 89(11):ECR39. PubMed ID: 15533844
[TBL] [Abstract][Full Text] [Related]
38. Translational medicine in action: anti-CD20 therapy in lymphoma.
Lim SH; Levy R
J Immunol; 2014 Aug; 193(4):1519-24. PubMed ID: 25086174
[TBL] [Abstract][Full Text] [Related]
39. Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma.
Betting DJ; Yamada RE; Kafi K; Said J; van Rooijen N; Timmerman JM
J Immunother; 2009; 32(6):622-31. PubMed ID: 19483647
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunotherapy for non-Hodgkin's lymphoma.
Liebenguth P; Vogt Temple S
Semin Oncol Nurs; 2006 Nov; 22(4):257-66. PubMed ID: 17095402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
